200 related articles for article (PubMed ID: 35223801)
41. Mussel-Inspired Polydopamine: The Bridge for Targeting Drug Delivery System and Synergistic Cancer Treatment.
Wang W; Tang Z; Zhang Y; Wang Q; Liang Z; Zeng X
Macromol Biosci; 2020 Oct; 20(10):e2000222. PubMed ID: 32761887
[TBL] [Abstract][Full Text] [Related]
42. Polydopamine Coated PB-MnO
Odda AH; Li H; Kumar N; Ullah N; Khan MI; Wang G; Liang K; Liu T; Pan YY; Xu AW
Bioconjug Chem; 2020 May; 31(5):1474-1485. PubMed ID: 32286806
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
44. A Polydopamine-Coated Platinum Nanoplatform for Tumor-Targeted Photothermal Ablation and Migration Inhibition.
Zou X; Ma G; Zhu P; Cao Y; Sun X; Wang H; Dong J
Front Oncol; 2022; 12():860718. PubMed ID: 35311136
[TBL] [Abstract][Full Text] [Related]
45. GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model.
Dai J; Li J; Zhang Y; Wen Q; Lu Y; Fan Y; Zeng F; Qian Z; Zhang Y; Fu S
Biomater Res; 2023 Oct; 27(1):105. PubMed ID: 37872620
[TBL] [Abstract][Full Text] [Related]
46. Folic Acid-Modified Erythrocyte Membrane Loading Dual Drug for Targeted and Chemo-Photothermal Synergistic Cancer Therapy.
Chen Z; Wang W; Li Y; Wei C; Zhong P; He D; Liu H; Wang P; Huang Z; Zhu W; Zhou Y; Qin L
Mol Pharm; 2021 Jan; 18(1):386-402. PubMed ID: 33296217
[TBL] [Abstract][Full Text] [Related]
47. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
48. Polydopamine-activated celastrol carbon dots for synergistic chemotherapy-photothermal therapy of tumors.
Sheng P; Bu C; Hui T; Zhou L; Chen H; Zhou G
Int J Pharm X; 2023 Dec; 6():100218. PubMed ID: 38033396
[TBL] [Abstract][Full Text] [Related]
49. A Versatile Platform Based on Black Phosphorus Nanosheets with Enhanced Stability for Cancer Synergistic Therapy.
Gao N; Nie J; Wang H; Xing C; Mei L; Xiong W; Zeng X; Peng Z
J Biomed Nanotechnol; 2018 Nov; 14(11):1883-1897. PubMed ID: 30165925
[TBL] [Abstract][Full Text] [Related]
50. Core-Shell-Shell Multifunctional Nanoplatform for Intracellular Tumor-Related mRNAs Imaging and Near-Infrared Light Triggered Photodynamic-Photothermal Synergistic Therapy.
Cen Y; Deng WJ; Yang Y; Yu RQ; Chu X
Anal Chem; 2017 Oct; 89(19):10321-10328. PubMed ID: 28872842
[TBL] [Abstract][Full Text] [Related]
51. Duo of (-)-epigallocatechin-3-gallate and doxorubicin loaded by polydopamine coating ZIF-8 in the regulation of autophagy for chemo-photothermal synergistic therapy.
Chen X; Tong R; Liu B; Liu H; Feng X; Ding S; Lei Q; Tang G; Wu J; Fang W
Biomater Sci; 2020 Mar; 8(5):1380-1393. PubMed ID: 31916560
[TBL] [Abstract][Full Text] [Related]
52. Polydopamine-Based Multifunctional Platform for Combined Photothermal Therapy, Chemotherapy, and Immunotherapy in Malignant Tumor Treatment.
Chen R; Zhu C; Fan Y; Feng W; Wang J; Shang E; Zhou Q; Chen Z
ACS Appl Bio Mater; 2019 Feb; 2(2):874-883. PubMed ID: 35016291
[TBL] [Abstract][Full Text] [Related]
53. An efficient antimicrobial depot for infectious site-targeted chemo-photothermal therapy.
Liu M; He D; Yang T; Liu W; Mao L; Zhu Y; Wu J; Luo G; Deng J
J Nanobiotechnology; 2018 Mar; 16(1):23. PubMed ID: 29548342
[TBL] [Abstract][Full Text] [Related]
54. Magnetic Resonance Imaging-Guided Multi-Drug Chemotherapy and Photothermal Synergistic Therapy with pH and NIR-Stimulation Release.
Yang JC; Chen Y; Li YH; Yin XB
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22278-22288. PubMed ID: 28616966
[TBL] [Abstract][Full Text] [Related]
55. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
56. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.
Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C
Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179
[TBL] [Abstract][Full Text] [Related]
57. CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells.
Guo Z; Liu Y; Zhou H; Zheng K; Wang D; Jia M; Xu P; Ma K; Cui C; Wang L
Colloids Surf B Biointerfaces; 2019 Dec; 184():110546. PubMed ID: 31606701
[TBL] [Abstract][Full Text] [Related]
58. Amyloid Protein-Biofunctionalized Polydopamine Nanoparticles Demonstrate Minimal Plasma Protein Fouling and Efficient Photothermal Therapy.
Han M; Li Y; Lu S; Yuan B; Cheng S; Cao C
ACS Appl Mater Interfaces; 2022 Mar; 14(11):13743-13757. PubMed ID: 35263991
[TBL] [Abstract][Full Text] [Related]
59. Responsive functionalized MoSe
Liu Y; Wei C; Lin A; Pan J; Chen X; Zhu X; Gong Y; Yuan G; Chen L; Liu J; Luo Z
Colloids Surf B Biointerfaces; 2020 May; 189():110820. PubMed ID: 32045843
[TBL] [Abstract][Full Text] [Related]
60. Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer.
You YH; Lin YF; Nirosha B; Chang HT; Huang YF
Nanotheranostics; 2019; 3(3):266-283. PubMed ID: 31263658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
